Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.35M Sell
6,685
-181
-3% -$64.5K 0.79% 29
2025
Q4
$2.25M Sell
6,866
-16
-0.2% -$5.08K 0.75% 27
2025
Q3
$1.94M Sell
6,882
-225
-3% -$65.3K 0.68% 32
2025
Q2
$1.98M Buy
7,107
+92
+1% +$26.1K 0.7% 38
2025
Q1
$2.19M Sell
7,015
-75
-1% -$22.1K 0.8% 32
2024
Q4
$1.85M Sell
7,090
-32
-0.4% -$9.49K 0.67% 37
2024
Q3
$2.29M Sell
7,122
-47
-0.7% -$15.4K 0.81% 28
2024
Q2
$2.24M Sell
7,169
-95
-1% -$27.9K 0.84% 31
2024
Q1
$2.07M Sell
7,264
-50
-0.7% -$14.6K 0.75% 34
2023
Q4
$2.11M Buy
7,314
+36
+0.5% +$9.81K 0.83% 31
2023
Q3
$1.96M Sell
7,278
-248
-3% -$61.9K 0.87% 28
2023
Q2
$1.67M Buy
7,526
+427
+6% +$99.1K 0.71% 35
2023
Q1
$1.72M Buy
7,099
+395
+6% +$97K 0.78% 28
2022
Q4
$1.76M Buy
6,704
+491
+8% +$132K 0.82% 29
2022
Q3
$1.4M Buy
6,213
+26
+0.4% +$6.3K 0.76% 30
2022
Q2
$1.5M Buy
6,187
+45
+0.7% +$11K 0.78% 31
2022
Q1
$1.49M Buy
6,142
+301
+5% +$69.2K 0.7% 37
2021
Q4
$1.31M Buy
5,841
+316
+6% +$66.7K 0.6% 43
2021
Q3
$1.18M Buy
5,525
+80
+1% +$18.4K 0.59% 43
2021
Q2
$1.33M Buy
5,445
+200
+4% +$49.2K 0.67% 36
2021
Q1
$1.3M Buy
5,245
+133
+3% +$31.7K 0.71% 37
2020
Q4
$1.18M Hold
5,112
0.67% 40
2020
Q3
$1.3M Sell
5,112
-25
-0.5% -$6.19K 0.85% 30
2020
Q2
$1.21M Sell
5,137
-78
-1% -$17.8K 0.82% 30
2020
Q1
$1.06M Buy
5,215
+615
+13% +$134K 0.83% 33
2019
Q4
$1.11M Buy
4,600
+90
+2% +$19.8K 0.68% 43
2019
Q3
$873K Buy
4,510
+133
+3% +$25.5K 0.56% 51
2019
Q2
$807K Buy
4,377
+116
+3% +$20.8K 0.57% 54
2019
Q1
$810K Buy
4,261
+360
+9% +$68.7K 0.59% 51
2018
Q4
$759K Buy
3,901
+9
+0.2% +$1.76K 0.63% 46
2018
Q3
$807K Sell
3,892
-77
-2% -$15.2K 0.57% 52
2018
Q2
$733K Buy
3,969
+955
+32% +$169K 0.66% 40
2018
Q1
$513K Buy
3,014
+40
+1% +$7.34K 0.46% 65
2017
Q4
$517K Sell
2,974
-5
-0.2% -$885 0.46% 65
2017
Q3
$556K Buy
2,979
+147
+5% +$26K 0.52% 57
2017
Q2
$488K Sell
2,832
-6
-0.2% -$976 0.48% 61
2017
Q1
$466K Sell
2,838
-9
-0.3% -$1.5K 0.45% 60
2016
Q4
$416K Buy
+2,847
New +$428K 0.41% 65

Other funds holding AMGN

LCNB Corp's AMGN Position: Q1 2026 in Review

LCNB Corp reduced its Amgen (AMGN) stake by 2.6% in Q1 2026, selling an estimated $64.5K and leaving 6,685 shares worth $2.35M. The position accounts for 0.79% of the portfolio, ranked #29.

LCNB Corp first reported a position in AMGN in Q4 2016 and has held it in 38 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • LCNB Corp held 6,685 shares of Amgen worth $2.35M as of Q1 2026.
  • LCNB Corp sold 181 Amgen shares in Q1 2026, an estimated $64.5K.
  • Amgen made up 0.79% of LCNB Corp's portfolio in Q1 2026, its #29 holding.
  • LCNB Corp first reported a position in Amgen in Q4 2016 and has held it in 38 quarters since.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on LCNB Corp's 13F filing for Q1 2026, filed 11 May 2026.